CD24 and breast cancer: Stratification of patients based on their CD47 and CD24 expression levels demonstrated a significant correlation with improved overall survival in individuals with lower CD47 expression among PC patients and lower CD24 expression among BC patients (Supplementary Fig. 17e, f).